Popular Articles
Grapefruit Benefits

Government Plan Could Sacrifice Equality For Choice In The NHS, UK
In a letter to this week÷´s BMJ, a researcher expresses his concern on how in order to empower NHS patients with choice, the UK government is in danger of sacrificing the principle of equality on which the service was founded.
generic viagra online
New Ways To Extend Professional Regulation
New alternatives to statutory regulation for currently unregulated health and occupational professions have been proposed by a specialist working group, Health Minister Ann Keen announced recently.
News of the day
The Alliance For The Advancement Of Adult Stem Cell Therapy And Research Announces Successful Treatment Of End-Stage Heart Disease With Stem Cells
Zannos Grekos, MD, Associate Clinical Professor at Nova Southeastern University, has announced six month follow-up results for a patient treated with adult stem cells in a clinical study of idiopathic dilated cardiomyopathy. The clinical study is a collaborative effort among physicians at Regenocyte Therapeutic, an American stem cell therapy clinic; researchers and scientists from Theravitae, a biotechnology company from Israel; and physicians from the American Institute for Regenerative Medicine, Dominican Republic.
Health Insurance

Erythropoietin Boosts Brainpower

Healthy young mice treated with erythropoietin show lasting improved performance in learning and other higher brain functions. Researchers writing in the open access journal BMC Biology tested the cognitive effects of the growth factor, finding that it improved the sequential learning and memory components of a complex long-term cognitive task. Hannelore Ehrenreich led a team of researchers from the Max Planck Institute of Experimental Medicine in Gç¶ttingen, Germany, who studied the mice. She said, "Erythropoietin has been in clinical use for over 20 years to treat patients with anemic conditions, ranging from renal failure to cancer. It has recently received attention for its apparent ability to improve cognitive function in people with schizophrenia and multiple sclerosis. Here, we sought to investigate erythropoietin"s effects in healthy mice". Ehrenreich and her colleagues tested the effects of erythropoietin on the ability of the mice to learn how to exploit an experimental set-up to receive sugared water. Over a series of learning stages, the mice were trained to get their treat by poking their noses into holes lit by LEDs, rather than into unlit holes, within a time limit. The mice that had been treated with recombinant human erythropoietin were significantly more likely to master the task than those that had not. According to Ehrenreich, "Treated mice showed superior performance in associative, operant and discriminant learning as well as in the initial training phases. Moreover, erythropoietin-treated mice demonstrated better task adaptation and higher performance stability". The researchers conclude, "Further untangling of molecular mechanisms of erythropoietin action on higher cognitive functions may ultimately open new avenues for prevention strategies and therapeutic interventions in neuropsychiatric diseases". Notes: Erythropoietin improves operant conditioning and stability of cognitive performance in mice Ahmed El-Kordi, Konstantin Radyushkin and Hannelore Ehrenreich BMC Biology Graeme Baldwin BioMed Central


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):